Biological Material Transfer Agreement Template for Singapore

A Biological Material Transfer Agreement is a legally binding contract that governs the transfer of biological materials between organizations in Singapore. This document establishes the terms, conditions, and restrictions for sharing biological samples, cell lines, genetic materials, or other biological substances for research, commercial, or educational purposes. Under Singapore's regulatory framework, these agreements are essential for ensuring compliance with multiple laws while protecting the interests of both providing and receiving parties.

When do you need this document?

You need a Biological Material Transfer Agreement whenever your organization is transferring or receiving biological materials across institutional boundaries. This includes transfers between research institutions and commercial biotechnology companies, international collaborations involving Singapore-based entities, and partnerships between government agencies and private organizations. The agreement is particularly crucial when dealing with controlled biological agents under BATA, human-derived materials governed by HBRA, or materials with potential commercial value. Academic researchers sharing cell lines, pharmaceutical companies providing samples for collaborative studies, and biotech startups accessing research materials all require these agreements to operate legally in Singapore.

Key legal considerations

Your agreement must clearly define the biological material being transferred, including its origin, characteristics, and any associated data or information. Use restrictions are critical and should specify the permitted research scope, whether commercial use is allowed, and any geographical limitations. Intellectual property clauses must address ownership of derivatives, modifications, and any discoveries made using the transferred material. Safety and compliance provisions should outline biosafety requirements, storage conditions, and disposal protocols. Liability and indemnification clauses protect both parties from potential risks associated with the material transfer. Publication and confidentiality terms govern how research results may be shared and what information remains confidential.

Legal requirements in Singapore

Singapore's Biological Agents and Toxins Act (BATA) requires licensing for possession and transfer of scheduled biological agents and toxins. Your agreement must ensure both parties hold appropriate BATA licenses where required and comply with security and safety protocols. The Human Biomedical Research Act (HBRA) governs transfers involving human tissues or samples, requiring institutional review board approval and appropriate consent procedures. Under the Animals and Birds Act, transfers of animal-derived materials must comply with animal welfare regulations. The Personal Data Protection Act (PDPA) applies when biological samples contain or are linked to personal information, requiring appropriate data protection measures. International transfers must also consider the Nagoya Protocol requirements for access and benefit-sharing of genetic resources, ensuring compliance with both Singapore law and international obligations.